Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high on Monday . The company traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares traded. The stock had previously closed at $21.24. Analysts Set New Price Targets Several brokerages have issued reports on […]
Truist Financial Reaffirms Hold Rating for Fusion Pharmaceuticals (NASDAQ:FUSN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
SVB Leerink reaffirmed their market perform rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $21.00 target price on the stock, up from their prior target price of $17.00. Several other equities analysts have also commented on […]